Sara Barrington
Chief Executive Officer bei VERICI DX PLC
Profil
Ms. Sara J.
Barrington is a Chief Executive Officer & Executive Director at Verici Dx Plc and a Chief Commercial Officer at Kantaro Biosciences LLC.
She is on the Board of Directors at LungLife AI, Inc. and Verici Dx Plc.
Ms. Barrington was previously employed as a CFO & EVP-Business Operations by Bruin Biometrics LLC, a Chief Financial Officer by Exosome Diagnostics, Inc., and a Chief Financial Officer by Ausam Biotechnologies, Inc. She also served on the board at Bruin Biometrics Europe Ltd.
She received her undergraduate degree from the University of Lancaster.
Aktive Positionen von Sara Barrington
| Unternehmen | Position | Beginn |
|---|---|---|
| VERICI DX PLC | Chief Executive Officer | 19.08.2020 |
| LUNGLIFE AI, INC. | Director/Board Member | 08.07.2021 |
Kantaro Biosciences LLC
 Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sara Barrington
| Unternehmen | Position | Ende |
|---|---|---|
| LUNGLIFE AI, INC. | Chief Executive Officer | 01.05.2020 |
Bruin Biometrics LLC
 Bruin Biometrics LLC Medical SpecialtiesHealth Technology Bruin Biometrics LLC manufactures biometric-sensor based medical devices. The company was founded by Martin Burns in 2009 and is headquartered in Los Angeles, CA. | Director of Finance/CFO | 01.11.2018 |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Director of Finance/CFO | 01.01.2014 |
Ausam Biotechnologies, Inc.
 Ausam Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Ausam Biotechnologies, Inc. provides biophysics and physiology research and development services. | Director of Finance/CFO | 01.01.2005 |
| Bruin Biometrics Europe Ltd. | Director/Board Member | - |
Ausbildung von Sara Barrington
| University of Lancaster | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LUNGLIFE AI, INC. | Health Services |
| VERICI DX PLC | Health Services |
| Private Unternehmen | 5 |
|---|---|
Ausam Biotechnologies, Inc.
Ausam Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Ausam Biotechnologies, Inc. provides biophysics and physiology research and development services. | Commercial Services |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |
Kantaro Biosciences LLC
Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. | Health Technology |
| Bruin Biometrics Europe Ltd. | |
Bruin Biometrics LLC
Bruin Biometrics LLC Medical SpecialtiesHealth Technology Bruin Biometrics LLC manufactures biometric-sensor based medical devices. The company was founded by Martin Burns in 2009 and is headquartered in Los Angeles, CA. | Health Technology |
